| |
Summer
Institute
on Longitudinal Research
August 13-15, 2008
Kevin Conway, Ph.D., National Institute on Drug Abuse
PRESENTATION/HANDOUTS:
"Severity of Addiction: The
Need for a New Instrument"
SELECTED REFERENCES:
Gillespie, N.A., Neale, M.C., Prescott, C.A., Aggen, S.H., & Kendler,
K.S. (2007). Factor and item-response analysis DSM-IV criteria
for abuse of and dependence on cannabis, cocaine, hallucinogens,
sedatives, stimulants and opioids. Addiction, 102, 920-930.
Kalivas, P.W., & O’Brien, C.P. (2008). Drug addiction
as a pathology of staged neuroplasticity. Neuropsychopharmacology,
33, 166-80.
Kendler, K.S., Prescott, C.A., Myers, J., & Neale, M.C. (2003). The
structure of genetic and environmental risk factors for common
psychiatric and substance use disorders in men and women. Archives
of General Psychiatry, 60, 929-937.
Koob, G. & Kreek, M.J. (2007). Stress, dysregulation of drug
reward pathways, and the transition to drug dependence. American
Journal of Psychiatry, 164, 1149-1159.
Krueger, R.F., Markon, K.E., Patrick, C.J., & Iacono, W.G.
(2005). Externalizing psychopathology in adulthood: A dimensional-spectrum
conceptualization and its implications for DSM-V. Journal of Abnormal
Psychology, 114, 537-550.
Uhl, G.R., Drgon, T., Johnson, C., Fatusin, O.O., Liu, Q.R., Contoreggi,
C., Li, C.Y., Buck, K., & Crabbe, J. (2008). Higher order
addiction molecular genetics: Convergent data from genome-wide
association in humans and mice. Biochemical Pharmacology, 75, 98-111.
Vanyukov, M.M., Kirisci, L., Tarter, R.E., Simkevitz, H.F.,
Kirillova, G.P., Maher, B.S., Clark, D.B. (2003). Liability to substance
use disorders: 2. A measurement approach. Neuroscience and Biobehavioral
Reviews, 27, 517-526.
(Back to Top)
|
|